Many women on GLP-1 medications notice changes in their menstrual cycle — some welcome, some surprising. Understanding why these changes happen helps you prepare and respond appropriately.
Adipose (fat) tissue is not just storage — it's hormonally active. Excess body fat increases estrogen production and disrupts the delicate balance of FSH, LH, and progesterone that governs the menstrual cycle. Losing fat directly shifts that balance.
Women with polycystic ovary syndrome often see some of the most dramatic cycle improvements. Improved insulin sensitivity reduces androgen production, which allows the hypothalamus–pituitary–ovary axis to function more normally. Some women who had not ovulated in years begin to again.
If you were previously relying on irregular cycles as informal contraception — that strategy may no longer be reliable. GLP-1 therapy should be paused before and during pregnancy, so if there is any chance of conception, discuss birth control options with your doctor proactively.
Getting 100g+ of protein daily on a reduced appetite is hard. Strategic timing makes it more achievable — and more effective for muscle preservation.
Medication helps with appetite. But the mental skills for sustainable weight management — resilience, flexibility, self-compassion — must be built intentionally.
People who share their journey with a community — online or in person — consistently achieve better outcomes. Here's why, and where to find yours.